Medtronic plc. stock is up 9.7% since 30 days ago. The next earnings date is Feb 20, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 58% of the previous 49 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 5 PUTs, 5 CALLs. 50% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
01 Dec 15:48 | 17 Jan, 2025 | 70.00 | 912 | ||
01 Dec 16:43 | 19 Jan, 2024 | 77.50 | 2951 | ||
01 Dec 18:06 | 19 Jan, 2024 | 90.00 | 35 | ||
01 Dec 18:42 | 17 May, 2024 | 65.00 | 206 | ||
04 Dec 14:52 | 16 Jan, 2026 | 80.00 | 104 | ||
04 Dec 19:07 | 17 May, 2024 | 72.50 | 109 | ||
05 Dec 15:16 | 17 Jan, 2025 | 50.00 | 200 | ||
05 Dec 16:27 | 17 May, 2024 | 72.50 | 188 | ||
05 Dec 19:12 | 17 May, 2024 | 90.00 | 12 | ||
06 Dec 14:35 | 21 Jun, 2024 | 67.50 | 142 |
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies. It operates through four segments: Cardiovascular, Neuroscience, Medical Surgical Portfolio, and Diabetes Operating Unit. The Neuroscience Portfolio segment offers products for spinal surgeons, neurosurgeons, neurologists; neurologists, pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists.